Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:developedBy |
theranostic radiopharmaceuticals
|
| gptkbp:focusesOn |
gptkb:cancer
targeted alpha therapy |
| gptkbp:foundedBy |
gptkb:Orano
|
| gptkbp:headquartersLocation |
gptkb:France
|
| https://www.w3.org/2000/01/rdf-schema#label |
Orano Med
|
| gptkbp:industry |
nuclear medicine
|
| gptkbp:operatesIn |
gptkb:France
gptkb:United_States |
| gptkbp:parentCompany |
gptkb:Orano
|
| gptkbp:specializesIn |
radioisotope production
|
| gptkbp:usesIsotope |
lead-212
|
| gptkbp:website |
https://www.oranomed.com/
|
| gptkbp:bfsParent |
gptkb:Orano
|
| gptkbp:bfsLayer |
6
|